FORMULATION INCLUDING ANTI-VEGFR2 ANTIBODY
The present invention relates to a formulation including an anti-VEGFR2 antibody. Specifically, the present invention relates to an anti-VEGFR2 antibody, a formulation including the anti-VEGFR2 antibody and a use thereof, in particular a pharmaceutical formulation including the anti-VEGFR2 antibody,...
Saved in:
Main Authors | , , , , , |
---|---|
Format | Patent |
Language | Chinese English French |
Published |
18.04.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention relates to a formulation including an anti-VEGFR2 antibody. Specifically, the present invention relates to an anti-VEGFR2 antibody, a formulation including the anti-VEGFR2 antibody and a use thereof, in particular a pharmaceutical formulation including the anti-VEGFR2 antibody, a buffering agent, a stabilizer and a surfactant. In addition, the present invention relates to a use of the formulation or the antibody in the prevention or treatment of diseases.
La présente invention concerne une formulation comprenant un anticorps anti-VEGFR2. Spécifiquement, la présente invention concerne un anticorps anti-VEGFR2, une formulation comprenant l'anticorps anti-VEGFR2 et son utilisation, en particulier une formulation pharmaceutique comprenant l'anticorps anti-VEGFR2, un agent tampon, un stabilisant et un tensioactif. De plus, la présente invention concerne une utilisation de la formulation ou de l'anticorps dans la prévention ou le traitement de maladies.
本发明涉及包含抗VEGFR2抗体的制剂。具体而言,本发明涉及抗VEGFR2抗体、 |
---|---|
Bibliography: | Application Number: WO2023CN123939 |